These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1888703)

  • 1. [Identification of a chromosome carrying a putative tumor suppressor gene in human choriocarcinoma by microcell-mediated chromosome transfer].
    Miyamoto S; Sasaki M; Nishida M; Wake N
    Hum Cell; 1991 Mar; 4(1):38-43. PubMed ID: 1888703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of IGF2 and H19 imprinting in choriocarcinoma development.
    Wake N; Arima T; Matsuda T
    Int J Gynaecol Obstet; 1998 Apr; 60 Suppl 1():S1-8. PubMed ID: 9833609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A study for the genesis of trophoblastic tumor, with reference to its androgenetic origin].
    Wake N
    Hokkaido Igaku Zasshi; 1984 Jan; 59(1):21-7. PubMed ID: 6325316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human chromosome 7 carries a putative tumor suppressor gene(s) involved in choriocarcinoma.
    Matsuda T; Sasaki M; Kato H; Yamada H; Cohen M; Barrett JC; Oshimura M; Wake N
    Oncogene; 1997 Dec; 15(23):2773-81. PubMed ID: 9419968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosome and cellular origin of choriocarcinoma.
    Wake N; Tanaka K; Chapman V; Matsui S; Sandberg AA
    Cancer Res; 1981 Aug; 41(8):3137-43. PubMed ID: 7195772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple chromosomes carrying tumor suppressor activity for a uterine endometrial carcinoma cell line identified by microcell-mediated chromosome transfer.
    Yamada H; Wake N; Fujimoto S; Barrett JC; Oshimura M
    Oncogene; 1990 Aug; 5(8):1141-7. PubMed ID: 2392323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant potential of homozygous and heterozygous complete moles.
    Wake N; Seki T; Fujita H; Okubo H; Sakai K; Okuyama K; Hayashi H; Shiina Y; Sato H; Kuroda M
    Cancer Res; 1984 Mar; 44(3):1226-30. PubMed ID: 6318983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The propensity to malignancy of dispermic heterozygous moles.
    Wake N; Fujino T; Hoshi S; Shinkai N; Sakai K; Kato H; Hashimoto M; Yasuda T; Yamada H; Ichinoe K
    Placenta; 1987; 8(3):319-26. PubMed ID: 2821529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes in gene expression profiles of hydatidiform mole and choriocarcinoma as compared with trophoblast hyperplasia].
    Cui JQ; Shi YF; Zhou HJ; Li JQ
    Zhonghua Zhong Liu Za Zhi; 2004 Dec; 26(12):727-31. PubMed ID: 15733390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of maspin in gestational trophoblastic disease.
    Li HW; Leung SW; Cheung AN; Yu MM; Chan LK; Wong YF
    Gynecol Oncol; 2006 Apr; 101(1):76-81. PubMed ID: 16271752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple human chromosomes carrying tumor-suppressor functions for the mouse melanoma cell line B16-F10, identified by microcell-mediated chromosome transfer.
    Kugoh H; Nakamoto H; Inoue J; Funaki K; Barrett JC; Oshimura M
    Mol Carcinog; 2002 Nov; 35(3):148-56. PubMed ID: 12410566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The propensity to malignancy of dispermic, heterozygous moles].
    Hashimoto M
    Hokkaido Igaku Zasshi; 1987 Jul; 62(4):564-72. PubMed ID: 2960601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The propensity to malignant changes in heterozygous moles].
    Seki T; Fujita H; Okubo H; Shiina Y; Wake N; Ichinoe K; Kuroda M; Satoh H
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Dec; 34(12):2221-8. PubMed ID: 7153599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell proliferative activity and mutation of P53 suppressor gene in human gestational trophoblastic disease.
    Persaud V; Ganjei P; Nadji M
    West Indian Med J; 1993 Dec; 42(4):142-3. PubMed ID: 7909185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current understandings of the molecular genetics of gestational trophoblastic diseases.
    Li HW; Tsao SW; Cheung AN
    Placenta; 2002 Jan; 23(1):20-31. PubMed ID: 11869089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetics of hydatidiform moles].
    Brackertz M
    Geburtshilfe Frauenheilkd; 1983 Jul; 43(7):461-8. PubMed ID: 6555112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successive activation of the platelet-derived growth factor beta receptor and platelet-derived growth factor B genes correlates with the genesis of human choriocarcinoma.
    Holmgren L; Flam F; Larsson E; Ohlsson R
    Cancer Res; 1993 Jun; 53(12):2927-31. PubMed ID: 8504434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relaxation of imprinting in trophoblastic disease.
    Ariel I; Lustig O; Oyer CE; Elkin M; Gonik B; Rachmilewitz J; Biran H; Goshen R; de Groot N; Hochberg A
    Gynecol Oncol; 1994 May; 53(2):212-9. PubMed ID: 8188082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular biology of gestational trophoblastic neoplasia: a review.
    Fulop V; Mok SC; Berkowitz RS
    J Reprod Med; 2004 Jun; 49(6):415-22. PubMed ID: 15283047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of c-onc genes in choriocarcinoma cells].
    Fujino T
    Hokkaido Igaku Zasshi; 1987 Sep; 62(5):798-807. PubMed ID: 3692432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.